BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Serum Institute of India, Ltd. 

212/2, Hadapsar
Off Soli Poonawalla Road
Pune    411042  India
Phone: 91-20-26993900 Fax: 91-20-26993921


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Merck & Co., Inc. (MRK) and Serum Institute of India, Ltd. Announce Collaboration to Develop and Expand Global Access to Pneumococcal Conjugate Vaccine (PCV) 8/3/2011 8:01:24 AM    More...
Billionaire-Led Serum Institute of India, Ltd.’s 50-Cent Vaccine Beats GlaxoSmithKline (GSK)’s Version in Study 6/16/2011 7:27:07 AM    More...
Akorn, Inc. (AKN) Announces First ANDA Submission For Serum Institute of India, Ltd. 12/5/2007 1:08:17 PM    More...
Dow Global Technologies Inc. Announces License Agreement with Serum Institute of India, Ltd. 2/27/2007 1:55:53 PM    More...
Akorn, Inc. (AKRN) And Serum Institute of India, Ltd. Announce The Signing Of A Definitive Development And Exclusive Distribution Agreement For Rabies Monoclonal Antibody 11/8/2006 12:33:41 PM    More...
Akorn, Inc. (AKRN) Announces Equity Investment By Serum Institute of India, Ltd. 9/8/2006 2:20:47 PM    More...
Lipoxen (LPX.L) Raises £2.6 Million Through Strategic Placing And Warrant Agreement With Serum Institute of India, Ltd. 8/3/2006 5:20:10 PM    More...
Akorn, Inc. (AKRN) And Serum Institute of India, Ltd. Announce The Signing Of An Exclusive Drug Development And Distribution Agreement For Oncology And Other Injectable Products 10/19/2005 5:11:50 PM    More...

//-->